Chengcai Liang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0001-7625-4574

发表论文 150 篇 · 总被引 867 次 · h-index 14

代表论文

• Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 12)
• Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer (2024 · Molecular Cancer · 被引 11)
• Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer (2025 · Cell Reports Medicine · 被引 7)
• Conversion Surgery After Trastuzumab-Based Chemotherapy and Immunotherapy for Stage IV HER2-Positive Gastric Cancer: A Retrospective Multicenter Cohort Study (2025 · Annals of Surgical Oncology · 被引 5)
• Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer (2026 · Cancer Cell · 被引 3)
• Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center study (2025 · BMC Cancer · 被引 2)